NCT00204464
- Conditions
- Amyotrophic Lateral Sclerosis, Behavior, Central Nervous System Diseases, +10 more
- Locations
-
- Cleveland Clinic Foundation Cleveland, Ohio, United States
Clinical trial condition
Proteostasis Deficiencies
Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.
1,350 public trials
353 recruiting studies
Proteostasis Deficiencies trial results
NCT00005674
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Washington University St Louis, Missouri, United States
NCT00056238
- Conditions
- Amyloidosis, Brain Diseases, Cardiovascular Diseases, +13 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Columbia University New York, United States
- University of Cincinnati Cincinnati, Ohio, United States
NCT00004771
- Conditions
- Amyotrophic Lateral Sclerosis, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +23 more
- Locations
-
Not specified
NCT00005766
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of Vermont Burlington, Vermont, United States
Active, Not Recruiting
Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
NCT06629818
- Conditions
- Amyloidosis, Light Chain (AL) Amyloidosis, Metabolic Diseases, +2 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Active, Not Recruiting
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
NCT07204977
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Frontotemporal Dementia With Motor Neuron Disease, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
HEALEY ALS Platform Trial - Master Protocol
NCT04297683
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- UC San Diego La Jolla, California, United States
Active, Not Recruiting
Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
NCT07716865
- Conditions
- Amyloidosis, Amyloidosis, Familial, Brain Diseases, +29 more
- Locations
-
- Landspitali University Hospital Reykjavik, Iceland
Active, Not Recruiting
FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
NCT04768972
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of California San Diego La Jolla, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States